The Institute of Medicine report on the FDA: where is the science?

Health Econ. 2007 Mar;16(3):219-21. doi: 10.1002/hec.1222.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cyclooxygenase 2 Inhibitors
  • Drug Approval / legislation & jurisprudence
  • Drug Approval / organization & administration*
  • Humans
  • Lactones
  • National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division*
  • Safety*
  • Sulfones
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence
  • United States Food and Drug Administration / organization & administration*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib